Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)

Objective: To compare the effect of sitagliptin (100 mg) vs glimepiride (1–3 mg) as add-on therapy in Indian type 2 diabetes (T2DM) patients on treatment with insulin and metformin (SWIM study). Research design and methods: This 24-week, controlled, open-label study randomized T2DM patients (n = 44...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jothydev Kesavadev, Pradeep Babu Sadasivan Pillai, Arun Shankar, Gopika Krishnan, Sunitha Jothydev
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Bioscientifica 2017-11-01
coleção:	Endocrine Connections
Assuntos:	glimepiride insulin metformin sitagliptin type 2 diabetes
Acesso em linha:	http://www.endocrineconnections.com/content/6/8/748.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!